1 / 6

Global Lung Cancer Drugs Market Report 2020

The global lung cancer market was valued at about $17.6 billion in 2018 and is expected to grow to $22.98 billion at a CAGR of 6.9% through 2022. Read more at http://bit.ly/37GD9B4

aleemtbrc
Télécharger la présentation

Global Lung Cancer Drugs Market Report 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Global Lung Cancer Drugs Lung Cancer Drugs Market | Global Industry Future Trends, Revenue Growth, and Leading Future Trends, Revenue Growth, and Leading Players 2020 2020- -2022 2022 Market | Global Industry Players Lung Cancer Drugs Global Market Report 2020 © The Business Research Company. All rights reserved. www.tbrc.info Email: info@tbrc.info

  2. • The lung cancer drugs market consists of sales of lung cancer drugs. Lung cancer is a type of cancer that decreases the ability of lungs to supply oxygen to the bloodstream because of uncontrolled growth of tissues in the lung. • The global lung cancer market was valued at about $17.6 billion in 2018 and is expected to grow to $22.98 billion at a CAGR of 6.9% through 2022. • The regions covered are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Lung Cancer Drugs Global Market Report 2020 2 © The Business Research Company. All rights reserved.

  3. Chapters from Table of Content Chapter 1. Executive Summary Chapter 2. Lung Cancer Drugs Market Characteristics Chapter 3. Lung Cancer Drugs Market Size And Growth Chapter 4. Lung Cancer Drugs Market Segmentation Chapter 5. Lung Cancer Drugs Market Regional And Country Analysis ……. Chapter 27. Lung Cancer Drugs Market Trends And Strategies Chapter 28. Product Pipeline Analysis Chapter 29. Lung Cancer Drugs Market Future Outlook and Potential Analysis Chapter 30. Appendix 3

  4. Companies Mentioned: Bristol-Myers Squibb Company, Merck & Co., F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc. Segments: • By Type • By Geography Request a Sample copy of this report 4 © The Business Research Company. All rights reserved.

  5. Few Points from List of Tables Table 1: Global Historic Market Growth, 2014-2018, $ Billion Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion Table 3: Global Lung Cancer Drugs Market, Segmentation By Disease Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion ……….. Table 67: F. Hoffmann-La Roche Ltd Financial Performance Table 68: Novartis AG Financial Performance Table 69: Pfizer Inc. Financial Performance 5

  6. Europe Asia Americas The Business Research Company 47 Anchorage Point, 42 Cuba Street, Canary Wharf, London, England, E14 8NE. +44 207 1930 708 Email: info@tbrc.info www.tbrc.info The Business Research Company, Horizon Avenue, 8-2-603/b/s/1/2 Road Number 10 Banjara Hills Hyderabad (India) 500033 ++91 8897263534 Email: info@tbrc.info www.tbrc.info The Business Research Company 625 South Avenue, Apt B204, Secane, Philadelphia, PA 19018, USA +1 3156230293 Email: info@tbrc.info www.tbrc.info Follow us on our social media and message us! 6 © The Business Research Company. All rights reserved.

More Related